← Open Payments lookup

SELMA ROSA: Open Payments

NPI 1457930158 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$295 in 12 payments from 9 companies in 2025. Trend: 2023 $328 · 2024 $48 · 2025 $295

Food & beverage: $295
CompanyPaymentsAmount
Alkermes, Inc.2$47
Neurocrine BioSciences, Inc.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$39
REVANCE THERAPEUTICS, INC.2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Otsuka America Pharmaceutical, Inc.1$28
Axsome Therapeutics, Inc.1$25
Solta Medical, a division of Bausch Health US, LLC1$23
Lundbeck LLC1$21

Products named: REXULTI, ARISTADA, TRINTELLIX, DAXXIFY, CAPLYTA, Auvelity, INGREZZA.

Industry payments across CT — which companies pay providers there.